Pulmonology
News from the FDA/CDC
Benralizumab Now FDA Approved to Treat EGPA Vasculitis
In a clinical trial, nearly 60% of participants achieved remission and 41% fully tapered off oral corticosteroids.
News from the FDA/CDC
FDA OKs Subcutaneous Atezolizumab Formulation for Multiple Cancer Indications
The drug combo was the first programmed death–ligand 1 inhibitor to gain approval for subcutaneous administration.
Conference Coverage
Osimertinib/Savolitinib Combo Shows Promise in NSCLC
Can combining two agents overcome MET-driven primary resistance in MET-aberrant, EGFR-mutated advanced NSCLC?
Latest News
Majority of Hospitalized Patients With COPD Misuse Inhalers
The results underscore the need for a comprehensive approach to inhaler use in hospitalized patients that combines continuous therapeutic...
Latest News
Genetic Testing and Novel Biomarkers Important in Cystic Fibrosis Diagnosis and Monitoring
Advances in genetic testing and newly discovered biomarkers can help screen newborns, monitor inflammation and exacerbations.
Latest News
Controversy Surrounds Optimal Treatment for High-Risk Pulmonary Embolism
Respiratory specialists debate whether rtPA, mechanical techniques or others are the best treatment for high-risk PE.
Conference Coverage
Ivonescimab: Possible New First-Line Standard in PD-L1–Positive Advanced NSCLC?
The results highlight ivonescimab’s potential to become a ‘new standard of care’ in advanced PD-L1–positive advanced NSCLC, according to an author...
Feature
Do Clonal Hematopoiesis and Mosaic Chromosomal Alterations Increase Solid Tumor Risk?
Researchers analyzed whole genome sequencing data from 10,866 women in the WHI to explore possible associations between CHIP, mCA, and solid...